selected publications
-
academic article
- Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment.. Frontiers in neurology. -. 2023
- Placental growth factor as a sensitive biomarker for vascular cognitive impairment.. Alzheimer's & dementia : the journal of the Alzheimer's Association. 19:3519-3527. 2023
- Age-Dependent Increase in Tau Phosphorylation at Serine 396 in Huntington's Disease Prefrontal Cortex.. Journal of Huntington's disease. 12:267-281. 2023
- Designing a quality assurance process for quality control of nuclear magnetic resonance metabolomics studies of human blood.. NMR in biomedicine. 36:-. 2022
- Plasma biomarkers for prognosis of cognitive decline in patients with mild cognitive impairment.. Brain communications. 4:-. 2022
- Technical Performance Evaluation of Olink Proximity Extension Assay for Blood-Based Biomarker Discovery in Longitudinal Studies of Alzheimer's Disease.. Frontiers in neurology. -. 2022
- A Nuclear Magnetic Resonance Spectroscopy Method in Characterization of Blood Metabolomics for Alzheimer's Disease.. Metabolites. 12. 2022
- Novel genetic variants in MAPT and alterations in tau phosphorylation in amyotrophic lateral sclerosis post-mortem motor cortex and cerebrospinal fluid.. Brain pathology (Zurich, Switzerland). 32:-. 2021
- MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.. Alzheimer's & dementia : the journal of the Alzheimer's Association. 17:704-715. 2021